Literature DB >> 14633117

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.

Arrigo Schieppati1, Giuseppe Remuzzi.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14633117     DOI: 10.1046/j.1523-1755.2003.00340.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  8 in total

Review 1.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

2.  Angiotensin blockade in children with chronic glomerulonephritis and heavy proteinuria.

Authors:  Lavjay Butani
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

3.  APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death.

Authors:  Yulong Fu; Jun-Yi Zhu; Adam Richman; Yi Zhang; Xuefang Xie; Jharna R Das; Jinliang Li; Patricio E Ray; Zhe Han
Journal:  J Am Soc Nephrol       Date:  2016-11-18       Impact factor: 10.121

Review 4.  Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Sankar D Navaneethan; Sagar U Nigwekar; Ashwini R Sehgal; Giovanni F M Strippoli
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

5.  Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis.

Authors:  Urara Mori-Takeyama; Shinya Minatoguchi; Ichijirou Murata; Hisayoshi Fujiwara; Yoko Ozaki; Michiya Ohno; Hiroshi Oda; Hiroshige Ohashi
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

6.  Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design.

Authors:  Howard Trachtman; Suzanne Vento; Debbie Gipson; Larysa Wickman; Jennifer Gassman; Melanie Joy; Virginia Savin; Michael Somers; Maury Pinsk; Tom Greene
Journal:  BMC Nephrol       Date:  2011-02-10       Impact factor: 2.388

Review 7.  Slowing the progression of adult chronic kidney disease: therapeutic advances.

Authors:  Maarten W Taal
Journal:  Drugs       Date:  2004       Impact factor: 11.431

8.  Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.

Authors:  Edmund Ym Chung; Marinella Ruospo; Patrizia Natale; Davide Bolignano; Sankar D Navaneethan; Suetonia C Palmer; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.